Previous studies have suggested that maximum tumor diameter (MTD) is a predictor of PSA recurrence or biochemical recurrence (BCR) in prostate cancer after radical prostatectomy (RP). The significance of MTD in BCR prediction was evaluated using RP specimens of 364 patients with a BCR of 18% (n ¼ 66) during a mean follow-up of 37.4 months (range: 10-109 months). MTD was defined as the largest diameter of the largest tumor, and its median MTD was 15 mm (range: 0.9-50 mm). MTD was significantly associated with pre-operative PSA levels, pathological T stage, Gleason's score and positive surgical margin. In a univariate analysis, pathological T stage, Gleason's score, positive surgical margin and MTD were associated significantly with the risk of BCR. Patients with 420 mm MTD had a significantly higher risk of BCR than did those with p20 mm MTD (Po0.001). Cox multivariate models indicated that pathological stage, Gleason's score, positive surgical margin and MTD were independent prognostic factors for BCR. MTD would be a useful tool for predicting BCR, as calculation of MTD is a simple and reliable measure.
Introduction
Although radical prostatectomy (RP) is a standard therapy for patients with clinically localized prostate cancer (PC), the 5-year PSA recurrence or biochemical recurrence (BCR) rate after RP remains between 15 and 40%. 1, 2 Previous studies have shown the relationship of BCR with several clinical parameters, including pre-operative PSA level, pathological stage, Gleason's score and surgical margin positivity. 3, 4 Total tumor volume (TTV) is another potential useful predictor of BCR. Some studies have shown that TTV is an independent predictor for BCR. 5, 6 However, the precise measurement of TTV is difficult and time consuming in the presence of multifocal tumors, which is a common observation in PC. Instead, a simpler parameter such as the maximum tumor diameter (MTD), the largest diameter of the largest tumor, may function as an indicator of tumor extension. Mizuno et al. 7 found that MTD rather than the maximum tumor area or TTV correlated more significantly with the extent of disease. In this study, we evaluated the prognostic value of MTD for BCR in patients with localized PC.
Materials and methods
Between January 2000 and March 2009, 607 patients were treated with RP for clinically localized PC at our institute. Of them, 243 cases were excluded from this analysis because of neo-adjuvant hormonal or radiation therapy, previous transurethral resection, incomplete data or mainly adjuvant hormonal therapy. Data obtained from the remaining 364 patients were analyzed. Tumors were staged using the AJCC (American Joint Committee on Cancer) TNM (tumor node metastasis) staging criteria of 2002.
The RP specimens were processed in a standardized manner for histological slides. Briefly, after fixation in 10% formalin, the prostate was sectioned vertically along the long axis at 3-mm intervals to prepare the wholemount sections. Direct marking on both ends of the tumor and measuring the distance on the slide glass determined the tumor diameter. MTD was defined as the largest diameter of the largest tumor. PSA values were obtained before surgery and at every follow-up point of 1-6 months. BCR after RP was defined as two sequential PSA levels above 0.20 ng ml À1 with at least 1 month apart. Patients with PSA nadir 40.2 ng ml À1 were classified as BCR at time 0. Gleason's score was divided into three groups of p6, 7 and X8. Associations between MTD and clinical or pathological characteristics were examined by univariate correlation. Proportional hazard multivariate regression models were composed to determine prognostic factors for BCR on Kaplan-Meier curves. BCR was compared between p20 and 420 mm of MTD using a log-rank test. 8 JMP version 8 (SAS Institute, Cary, NC, USA) for Windows was used for all statistical analysis. In all tests, differences were considered statistically significant at Po0.05.
Results
Patient backgrounds are summarized in Table 1 . Patients were 66 years old at the time of surgery (median: range 52-78) with a pre-operative PSA level of 8.1 ng ml
À1
(median: range 1.7-77.7). Gleason's score and the MTD of the surgical specimens were 7 (median: range 4-9) and 15 mm (median: range 0.9-50), respectively. The followup period was 33 months (median: range 10-109 months). BCR occurred in 66 of 364 men (18.1%) ( Table 2 ) and the time to BCR was 11 months (median: range 0-51 months). BCR was significantly associated with MTD among four groups of the MTD in the univariate analysis (P ¼ 0.017) ( Table 2 ). MTD was significantly associated with pre-operative PSA levels (Po0.01), pathological stage (Po0.01), Gleason's score (Po0.01), surgical margin status (Po0.01) and BCR (Po0.01) ( Table 3 ). Time to BCR was also significantly associated with pathological stage, Gleason's score, positive surgical margin and MTD in the univariate analysis (Table 4) . In proportional hazard multivariate regression models, advanced pathological stage (P ¼ 0.003), higher Gleason's score (P ¼ 0.019), positive margin status (Po0.001) and larger MTD (P ¼ 0.037) still remained as significant independent prognostic factors for BCR (Table 4 ). In a cohort of smaller MTD (0.9-30 mm, n ¼ 334), advanced pathological stage (P ¼ 0.001), higher Gleason's score (P ¼ 0.008), positive margin status (Po0.001) and larger MTD (420 against p20 mm, P ¼ 0.023) were also significant independent prognostic factors for BCR. On the other hand, MTD as a continuous variable was significantly associated with the time to BCR in multivariate analysis (P ¼ 0.037) only in a subgroup of small MTD (0.9-20 mm, n ¼ 266).
The significance was lost in the subgroup of MTD (0.9-30 mm, n ¼ 334) or in the whole group (0.9-50 mm, n ¼ 364) (P ¼ 0.542 or P ¼ 0.488, respectively). Estimated BCR-free curves were clearly different between subgroups of MTD p20 and 420 mm (log-rank test Po0.001, Figure 1 ). 
Discussion
Prediction of BCR after prostatectomy is imperative in counseling with patients on adjuvant therapy and prognosis. Intuitively, BCR should be associated with tumor burden. Carvalhal et al. stated that the ratio of tumor volume to the whole RP specimens was an independent predictor of BCR after RP in the analysis of 595 RP patients. The ratio of tumor volume in the RP specimen was 11.3% in BCR-free men, whereas it was 23.8% in men who experienced BCR. 5 Nelson et al.
9
found that TTV was an independent predictor of BCR (P ¼ 0.04) in 431 patients with localized PC after RP. Although TTV in the RP specimen should be certainly associated with BCR, it remains controversial whether it is an independent prognostic factor. Epstein et al.
10
mentioned that TTV did not provide additional information beyond Gleason's score and the status of the capsular margin status in the analysis of 185 RP specimens. Salomon et al. 11 also showed that tumor progression correlated only with Gleason's score and tumor stage in a multivariate analysis, whereas it correlated with TTV in a univariate analysis in 200 RP specimens. Kikuchi et al.
12 also showed TTV was not a significant independent predictor of BCR in the analysis of 1302 RP specimens when considered in multivariate analysis controlling Gleason's score and pathological stage. Ohori et al. 13 stated that TTV provides no additional prognostic information on BCR in their review article. These conflicting results are partly explained by the difficulty in estimating TTV.
Most RP specimens contain the index tumor (the largest tumor) and smaller satellite tumors.
14 Noguchi et al. 15 found that only index tumor volume, but not TTV, was an independent predictor of BCR. They classified 222 men with T1c PC into three groups according to satellite tumors: a single index tumor (n ¼ 54, 24%), an index tumor with satellite tumors o0.5 ml (n ¼ 86, 39%) and an index tumor with satellite tumors 40.5 ml (n ¼ 82, 37%). When comparing BCR rates among these three groups, the multifocal group with smaller satellite tumors showed a better prognosis than did the single tumor group (P ¼ 0.019). This would mean that small satellite tumors might be clinically irrelevant and it is the index tumor to be evaluated for the BCR prediction. Wise et al. 16 examined the significance of additional estimate of satellite tumor volumes in postoperative BCR prediction in 486 patients. The mean index tumor volume was 4.16 ml and satellite tumor volumes averaged 0.63 ml. The Cox regression model showed similar hazard ratios of BCR with the index tumor volume alone (3.43) and TTV (3.74). These investigations indicated the importance of the index tumor rather than all tumors in RP specimens to predict prognosis.
Some studies focused on MTD as a predictor for BCR, as MTD can be a surrogate of tumor volume. Renshaw et al. 17 noted that MTD was an independent risk factor for BCR in a multivariate logistic model of 434 RP specimens (P ¼ 0.0006). Only 15% of patients with o1 cm MTD experienced BCR, compared with 73% of men with 42 cm MTD. 17, 18 Mizuno et al. 8 also showed that MTDX2 cm was independently associated with higher risk of BCR in 164 patients undergoing RP for localized PC (P ¼ 0.015). They divided patients into three risk groups of low (MTDo2.0, Gleason's score p6 and negative surgical margin), intermediate (one risk factor, MTDX2.0 or Gleason's score 7, positive surgical margin) and high (all others). The differences in the 3-and 5-year BCR rates among these three risk-groups were significant (Po0.001). According to these results, the analysis was performed between 420 and p20 mm of MTD in our study. Eichelberger et al. 19, 20 confirmed the positive correlation between MTD and the risk of BCR in their study of 364 men; increased MTD was associated with shorter time to BCR (P ¼ 0.01) after controlling for risk factors, such as Gleason's score and surgical margins in Cox multiple regression models. They also found that MTD was significantly correlated with pre-operative PSA levels, prostate weight, TTV, Gleason's score and pathological stage. In our study, MTD was similarly associated significantly with pre-operative PSA level, pathological stage, Gleason's score and margin status (all Po0.01), and furthermore, it was an independent predictor of BCR in the multivariate analysis. In the current study, we confirmed a significant association of MTD with the time to BCR in multivariate analysis. Considering the simplicity in measurement, MTD would be a clinically useful indicator for BCR.
To the contrary, van Oort et al. 21 demonstrated that MTD provided no additional information for the risk of BCR in multivariate analysis of 542 patients, although it was weakly associated with BCR in univariate analysis. Dvorak et al. 22 showed that the significance of MTD in predicting BCR (P ¼ 0.004) was lost (P ¼ 0.07) when surgical margin status was included in the Cox model of 781 men. In these two studies, multivariate analyses indicated that positive surgical margin was one of the major prognostic factors for BCR irrespective of the risk profile. The discrepancy may be explained by the difference of the cohorts. A large median MTD of 15 mm in our study sample might have caused misleading statistical significance due to biased patient selection, although there was no discernible tendency suggesting that the analysis of samples with larger tumors resulted in or against favor of MTD as the predictor in the previous reports 8, [17] [18] [19] [20] [21] [22] . For this possibility, we analyzed a cohort of smaller MTD (n ¼ 334, 0.9-30 mm), confirming MTD predicting PSA recurrence H Fukuhara et al that MTD was still a significant factor for the time to BCR in this cohort in multivariate analysis (P ¼ 0.023). On the other hand, the significance of MTD was lost in the multivariate analysis using MTD as continuous data. The significance was retained when only those of MTDp20 mm were analyzed. These findings may indicate that MTD is more significant a factor in cohorts with smaller tumor size, suggesting the utility in contemporary series of early detected PC. Further study is required to determine the precise position of MTD in BCR prediction.
Conclusions
The results of our study indicated that pathological stage, Gleason's score, positive surgical margin and MTD were independent prognostic factors for BCR. MTD would be a useful tool for predicting BCR, as the calculation of MTD is a simple and reliable measure.
